These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37929565)

  • 1. Nonischemic or Dual Cardiomyopathy in Patients With Coronary Artery Disease.
    Bawaskar P; Thomas N; Ismail K; Guo Y; Chhikara S; Athwal PSS; Ranum A; Jadhav A; Hooker Mendez A; Nadkarni I; Frerichs D; Velangi P; Ergando T; Akram H; Kanda A; Shenoy C
    Circulation; 2024 Mar; 149(11):807-821. PubMed ID: 37929565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
    Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
    JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic cardiomyopathy is associated with coronary plaque progression and higher event rate in patients after cardiac transplantation.
    Guddeti RR; Matsuo Y; Matsuzawa Y; Aoki T; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25095871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.
    Aldhoon B; Tzou WS; Riley MP; Lin D; Callans DJ; Hutchinson MD; Dixit S; Garcia FC; Zado ES; Marchlinski FE
    Heart Rhythm; 2013 Nov; 10(11):1622-7. PubMed ID: 23973949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of embolic risk in left ventricular thrombus between nonischemic and ischemic cardiomyopathy: A nationwide database analysis.
    Fujino M; Aikawa H; Nakao K; Takagi K; Otsuka F; Kataoka Y; Asaumi Y; Sumita Y; Nakai M; Kanaoka K; Miyamoto Y; Nicholls SJ; Noguchi T
    Int J Cardiol; 2024 Sep; 411():132329. PubMed ID: 38964554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Power of Quantitative Assessment of Functional Mitral Regurgitation and Myocardial Scar Quantification by Cardiac Magnetic Resonance.
    Wang TKM; Kocyigit D; Choi H; Anthony CM; Chan N; Bullen J; Popović ZB; Kapadia SR; Krishnaswamy A; Griffin BP; Flamm SD; Tang WHW; Kwon DH
    Circ Cardiovasc Imaging; 2023 Aug; 16(8):e015134. PubMed ID: 37503633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Individual Patient-Level Meta-Analysis of Ischemic Versus Nonischemic Cardiomyopathy and Trajectory of Decongestion in Patients With Acute Decompensated Heart Failure.
    Akhtar KH; Maqsood MH; Ansari SA; Siddiqi TJ; Arshad MS; Greene SJ; Butler J; Khan MS
    Am J Cardiol; 2023 Aug; 200():32-39. PubMed ID: 37295177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of Nonobstructive Coronary Artery Disease in the Prognosis of Patients With Heart Failure.
    Braga JR; Austin PC; Ross HJ; Tu JV; Lee DS
    JACC Heart Fail; 2019 Jun; 7(6):493-501. PubMed ID: 31078476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of Clustered Ventricular Arrhythmia and Cycle Length With Scar Burden in Cardiomyopathy.
    Vakil RM; Marine JE; Kolandaivelu A; Dickfeld T; Weiss RG; Tomaselli GF; Chrispin J; Wu KC
    JACC Clin Electrophysiol; 2022 Aug; 8(8):957-966. PubMed ID: 35981800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the Clinical Outcome of Ischemic and Nonischemic Cardiomyopathy in Heart Failure With Concomitant Opioid Use Disorder.
    Gharbin J; Winful A; Hassan MA; Bajaj S; Batta Y; Alebna P; Rhodd S; Taha M; Fatima U; Mehrotra P
    Curr Probl Cardiol; 2023 May; 48(5):101609. PubMed ID: 36690309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype, outcomes and natural history of early-stage non-ischaemic cardiomyopathy.
    Hammersley DJ; Jones RE; Owen R; Mach L; Lota AS; Khalique Z; De Marvao A; Androulakis E; Hatipoglu S; Gulati A; Reddy RK; Yoon WY; Talukder S; Shah R; Baruah R; Guha K; Pantazis A; Baksi AJ; Gregson J; Cleland JGF; Tayal U; Pennell DJ; Ware JS; Halliday BP; Prasad SK
    Eur J Heart Fail; 2023 Nov; 25(11):2050-2059. PubMed ID: 37728026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Role of Primary Heart Failure Etiology on Cardiac Transplant Outcomes.
    Firoz A; Yanagida R; Kashem M; Toyoda Y; Hamad E
    Clin Transplant; 2024 Sep; 38(9):e15450. PubMed ID: 39215432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordant and Discordant Cardiac Magnetic Resonance Imaging Delayed Hyperenhancement Patterns in Patients with Ischemic and Non-Ischemic Cardiomyopathy.
    Kim EK; Chang SA; Choi JO; Glockner J; Shapiro B; Choe YH; Fine N; Jang SY; Kim SM; Miller W; Lee SC; Oh JK
    Korean Circ J; 2016 Jan; 46(1):41-7. PubMed ID: 26798384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
    Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
    BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular free wall strain in acutely decompensated heart failure patients with ischemic and non-ischemic cardiomyopathy.
    Miric D; Barac A; Capkun V; Bakovic D
    Echocardiography; 2021 Oct; 38(10):1747-1753. PubMed ID: 34555211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating Nonischemic Dilated Cardiomyopathy With Incidental Infarction From Ischemic Cardiomyopathy by Geometric Indices Derived From Cardiovascular Magnetic Resonance.
    Wang X; Costello BT; Papapostolou S; O'Brien J; Taylor A; Zhao S
    J Thorac Imaging; 2021 Jul; 36(4):248-253. PubMed ID: 32960835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography absolute stress myocardial blood flow for risk stratification in nonischemic cardiomyopathy.
    Middour TG; Rosenthal TM; Abi-Samra FM; Bernard ML; Khatib S; Polin GM; Rogers PA; Bober RM; Morin DP
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1137-1146. PubMed ID: 32064730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.